CHINA AND INDIA PHARMCEUTICAL SECTORS PLOT DEVELOPMENT OF ORIGINAL MEDICINES FOR GLOBAL MARKETS
March 1st, 2011
BY WANG FANGQING and MINI PANT ZACHARIAH
THAT China and India sport efficient pharmaceutical sectors producing generic medicines with vigorous efficiency has long been a fact of life for the global pharma sector. But the ambitions of their domestic industries to produce original medicines that can seize world markets is a newer phenomenon, but a serious one - multinational pharmaceutical companies should take note.
Indeed China's determination to develop patented drugs was made crystal clear last month (February), when a senior pharma research institute was set ...
Full access to this article can be arranged with permission from the client that first ordered it. Please contact us to request access. Entries are uploaded to our archive at least one year after being published by a client – free access is restricted to International News Services journalists for background research only. The article date indicates when copy was filed to a client, not when posted to this archive. Upon client requests, International News Services will remove such articles from the archive or not upload them in the first place. They are included to demonstrate the breadth of topics undertaken by the agency and also to help promote clients’ coverage.